Related Content
- Six retailers charge Wyeth, Teva with unlawfully delaying generic Effexor XR
- Report: Pfizer seeks aid of PBMs in efforts to block generic versions of Lipitor
- Pfizer's Germano to speak at 2011 Armada Specialty Pharmacy Summit
- Mylan gets approval for generic version of Vfend
- Moving PSE to Rx-only in Mo. lacks fiscal sense
PITTSBURGH — The Food and Drug Administration has approved a generic drug for depression and anxiety made by Mylan, the drug maker said Thursday.
Mylan announced the approval of venlafaxine hydrochloride extended-release capsules in the 37.5-mg, 75-mg and 150-mg strengths.
The drug, used to treat major depressive disorder and social anxiety disorder, is a generic version of Effexor XR, made by Wyeth. Mylan is launching the drug under a licensing agreement it made with Wyeth before its purchase by Pfizer.
Velafaxine hydrochloride extended-release capsules had sales of $2.3 billion during the 12 months ended in March, according to IMS Health.
